Document Details
Form
Filing Date
Mar 31, 2022
Document Date
Mar 29, 2022
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
AN2 Therapeutics, Inc
Issuer
AN2 THERAPEUTICS, INC.
Filer
Adjuvant Global Health Technology Fund, L.P.
